IPP Bureau

Indoco’s clinical research organisation ‘AnaCipher’ completes USFDA inspection
Indoco’s clinical research organisation ‘AnaCipher’ completes USFDA inspection

By IPP Bureau - March 11, 2025

Emcure partners with Vidya Balan for Arth supplements,
Emcure partners with Vidya Balan for Arth supplements,

By IPP Bureau - March 11, 2025

Vidya will spark conversations around less discussed and important aspects of health, including intimate care and sleep issues

Zota Health Care launched B2C online portal ‘davaindia’
Zota Health Care launched B2C online portal ‘davaindia’

By IPP Bureau - March 11, 2025

This e-commerce platform is launched as a hyperlocal model

Glenmark Nutrition Awards 2025 celebrates innovation and impact in fight against malnutrition
Glenmark Nutrition Awards 2025 celebrates innovation and impact in fight against malnutrition

By IPP Bureau - March 10, 2025

403 entries from 22 states covering 168 districts highlight groundbreaking initiatives vital to improving national nutrition metrics.

Sun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics
Sun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics

By IPP Bureau - March 10, 2025

Will add UNLOXCYT (cosibelimab-ipdl), the first and only FDA-approved anti-PD-L1 treatment for metastatic or locally advanced cutaneous squamous cell carcinoma (cSCC) to Sun Pharma's global onco-derm franchise

Astellas and YASKAWA to establish JV focused on cell therapy manufacturing
Astellas and YASKAWA to establish JV focused on cell therapy manufacturing

By IPP Bureau - March 10, 2025

Astellas stands on the forefront of healthcare change to turn innovative science into value for patients

Zydus receives final approval from USFDA for Ketoconazole Shampoo, 2%
Zydus receives final approval from USFDA for Ketoconazole Shampoo, 2%

By IPP Bureau - March 10, 2025

Ketoconazole shampoo is an antifungal medication used to treat dandruff

Biocon Biologics announces positive results from Phase 3 study of Yesintek biosimilar to Ustekinumab for chronic plaque psoriasis
Biocon Biologics announces positive results from Phase 3 study of Yesintek biosimilar to Ustekinumab for chronic plaque psoriasis

By IPP Bureau - March 08, 2025

The study demonstrated equivalent efficacy, safety, immunogenicity, and pharmacokinetics between YESINTEK and the reference product Stelara

Amaran Biotech signs MOU with Nippon Fine Chemical to expand CDMO business
Amaran Biotech signs MOU with Nippon Fine Chemical to expand CDMO business

By IPP Bureau - March 08, 2025

Amaran Biotech boasts Taiwan’s first fully automated robotic aseptic filling line, offering high-quality and low-waste filling solutions for high-value pharmaceuticals

Bionova opens Fremont process development and pilot plant
Bionova opens Fremont process development and pilot plant

By IPP Bureau - March 07, 2025

Eris Lifesciences appoints Murari Ranganathan to drive cardiometabolic business
Eris Lifesciences appoints Murari Ranganathan to drive cardiometabolic business

By IPP Bureau - March 07, 2025

Prior to joining Eris, Ranganathan was Commercial Director, Women's Health, Metabolics, and International Business at Abbott India Limited

Dr. Agarwals Eye Hospital inaugurates its third facility in Mysore
Dr. Agarwals Eye Hospital inaugurates its third facility in Mysore

By IPP Bureau - March 07, 2025

This addition strengthens Dr. Agarwals Eye Hospital's vast network of 28 hospitals across Karnataka and 220+ facilities worldwide

Fermenta's plant-based Vitamin D3 is 'Innovation of the Year'
Fermenta's plant-based Vitamin D3 is 'Innovation of the Year'

By IPP Bureau - March 07, 2025

VITADEETM Green is a 100% plant-based Vitamin D3 suitable for food & nutraceuticals

Biocon Biologics and Civica collaborate to expand Insulin Aspart access in US
Biocon Biologics and Civica collaborate to expand Insulin Aspart access in US

By IPP Bureau - March 07, 2025

There are 38.4 million people with diabetes in the United States

India’s biotech economy set to reach a massive $300 bn by 2030: Dr. Jitendra Singh
India’s biotech economy set to reach a massive $300 bn by 2030: Dr. Jitendra Singh

By IPP Bureau - March 07, 2025

Biotech potential of Himalayan territories including Jammu & Kashmir, particularly their agri-biotech potential remains still under-explored

Latest Stories

Interviews

Packaging